Envenenamiento por Metales Pesados

Allicin, the active sulfur compound from garlic, is particularly effective against methane-producing microbes associated with methane-dominant SIBO (intestinal methanogen overgrowth). The 2014 Chedid et al. study included allicin-based herbal protocols that outperformed rifaximin for SIBO breath-test normalization. Stabilized allicin supplements deliver the compound directly to the small intestine, targeting gram-negative bacterial species such as E. coli, Klebsiella, and Citrobacter implicated in hydrogen-dominant SIBO.

Bacillus clausii was specifically studied for SIBO treatment in a published clinical trial (Gabrielli et al., 2009, American Journal of Gastroenterology), showing comparable hydrogen breath-test normalization rates to antibiotic therapy. It is listed in the 2017 Zhong meta-analysis as among probiotic strains demonstrating SIBO decontamination efficacy.

Bacillus coagulans is a spore-forming probiotic listed in clinical SIBO treatment guidelines due to its ability to survive stomach acid and reach the small intestine intact. A 2023 meta-analysis of RCTs found B. coagulans improved IBS symptoms—including abdominal pain and bloating—that commonly overlap with SIBO. It is included in Optimal DX SIBO clinical protocols.

Berberine, a plant alkaloid from Berberis, Coptis, and related genera, has been studied head-to-head against rifaximin for SIBO. A 2014 study (Global Advances in Health and Medicine) found herbal protocols containing berberine achieved 46% breath-test normalization versus 34% with rifaximin. A PMC-published RCT protocol (BRIEF-SIBO study) directly evaluated berberine as a single agent against rifaximin in SIBO patients, documenting its modulation of gut microbiota composition and reduction of pathogenic bacteria.

Bifidobacterium species are included in SIBO probiotic protocols and the 2017 Zhong meta-analysis (18 studies, J Clin Gastroenterol). This meta-analysis found probiotic regimens containing Bifidobacterium strains effectively decontaminated the small intestine in 53.2–62.8% of cases and significantly reduced abdominal pain and hydrogen gas concentrations in SIBO patients.

Bifidobacterium longum was specifically used as post-antibiotic SIBO treatment support in a clinical study protocol (Redondo-Cuevas), and is included in the SIBO probiotic evidence reviewed by the 2017 Zhong meta-analysis. It reduces intestinal permeability and supports microbiome rebalancing after SIBO eradication.

In SIBO, excess bacteria in the small intestine deconjugate bile salts before they can form micelles, directly impairing fat digestion and causing fat malabsorption and diarrhea. The Mayo Clinic and clinical literature identify bile salt deconjugation as a primary mechanism of fat malabsorption and diarrhea in SIBO. Deconjugated bile salts are less efficiently reabsorbed and more cytotoxic, potentially injuring intestinal epithelium.

Carvacrol is the primary active antimicrobial compound of oregano oil and thyme oil, with well-documented biocidal activity against gram-positive and gram-negative bacteria implicated in SIBO. Multiple in vitro studies and the 2014 Chedid et al. clinical study (Global Advances in Health and Medicine) support carvacrol-containing preparations as effective as rifaximin for SIBO breath-test normalization.

SIBO is associated with reduced DAO levels due to bacterial damage to small intestinal villi, and simultaneously increases luminal histamine production, creating a reinforcing cycle of DAO deficiency and histamine intolerance. Serum DAO is lower in patients with SIBO than those without, as documented in clinical studies.

Garlic is used in SIBO treatment due to its allicin content, which is particularly effective against methane-producing archaea in methane-dominant SIBO. Herbal protocols incorporating garlic-derived allicin were shown in the 2014 Chedid et al. study to outperform rifaximin for SIBO breath-test normalization. Supplement-grade stabilized allicin extracts (not whole garlic) are preferred to avoid high-FODMAP fructans.

Ginger is used in SIBO management primarily as a natural prokinetic agent that enhances gastric motility and stimulates the migrating motor complex (MMC), reducing bacterial stasis and overgrowth recurrence. Clinical and pharmacological research confirms ginger's prokinetic properties, and clinical SIBO protocols recommend it (500–1,000 mg at night) to prevent relapse by maintaining gut motility after SIBO eradication.

SBI is clinically used as a medical food for managing chronic diarrhea in SIBO, per the published Wikipedia entry on EnteraGam and retrospective clinical series. Its IgG content binds bacterial antigens, potentially normalizing the microbial environment of the small intestine. Evidence is primarily clinical series and retrospective data rather than RCTs specific to SIBO.

Inulin, a prebiotic fiber, is identified in SIBO dietary literature as both a potentially beneficial and cautionary supplement. Authoritative sources (Nutrients 2022 narrative review cited by the Institute for Natural Medicine) include inulin as a soluble fiber supplement that may help manage SIBO symptoms, though high doses can worsen bloating by providing fermentable substrate for bacteria.

L-glutamine is used as supportive therapy in SIBO to repair intestinal barrier integrity compromised by bacterial overgrowth. Clinical SIBO protocols include L-glutamine (5 g twice daily) as a gut-lining repair agent post-antibiotic therapy. It is recognized by functional medicine practitioners and cited in published SIBO studies as supporting mucosal healing and reducing intestinal permeability.

Lactobacillus acidophilus has been studied in SIBO, with small studies showing comparable hydrogen breath-test normalization rates to antibiotic therapy. A 2017 meta-analysis (J Clin Gastroenterol, 18 studies) found that probiotics including L. acidophilus effectively decontaminated the small intestine in 53.2–62.8% of SIBO cases. Combined use with antibiotics increased decontamination rates to 85.8%.

Lactobacillus plantarum has demonstrated efficacy in SIBO-associated symptom reduction. Studies show L. plantarum 299v improved IBS symptoms linked to SIBO, and one study found L. plantarum outperformed antibiotics for functional abdominal bloating. The 2017 meta-analysis confirmed its role in small-intestinal decontamination and symptom improvement.

Lactobacillus rhamnosus (especially strain GG) has been included in SIBO probiotic protocols based on its well-documented effects on intestinal permeability and immune modulation. Clinical evidence places it among probiotic strains with evidence for managing SIBO-related gut dysbiosis and symptoms, including its recognition in systematic reviews and clinical protocol documents.

Peppermint oil demonstrates in vitro antibacterial activity against small intestinal bacteria, with activity against enteric pathogens relevant to SIBO. Laboratory evidence shows peppermint EO outperforms rifaximin (the antibiotic of choice for SIBO) in disc diffusion assays against E. coli. Clinical trials specifically for SIBO are absent, but mechanistic evidence is strong.

Monolaurin has in vitro activity against bacteria implicated in small intestinal bacterial overgrowth (including gram-positive organisms, H. pylori, and some gram-negatives). It is used in functional medicine SIBO protocols based on its broad antimicrobial spectrum and the premise that it spares beneficial bacteria. No human SIBO-specific clinical trials have been published.

N-Acetyl Cysteine (NAC) is used in SIBO treatment as a biofilm disruptor. NAC breaks disulfide bonds in bacterial biofilm matrices, exposing embedded bacteria to concurrent antimicrobials. Published clinical evidence (Cureus, PMC12701763) includes its use in herbal SIBO antimicrobial protocols, and Del Piano et al. found a regimen combining Lactobacillus strains with NAC significantly reduced small bowel bacterial overgrowth.

Oregano oil, standardized to carvacrol and thymol, is one of the most-studied herbal antimicrobials for SIBO. The 2014 Chedid et al. study included oregano-containing herbal protocols that achieved breath-test normalization comparable to or exceeding rifaximin. In vitro studies document carvacrol's biocidal activity against gram-positive and gram-negative bacteria found in the jejunum, ileum, and colon, and anti-biofilm properties relevant to treatment-resistant SIBO.

Peppermint oil is used in SIBO management as both a natural antimicrobial and prokinetic agent. Its active compound menthol relaxes smooth muscle and stimulates gut motility, while its antimicrobial properties help reduce bacterial load. Multiple functional medicine SIBO protocols and clinical reviews cite peppermint oil for SIBO symptom relief and relapse prevention.

Psyllium is a soluble fiber recommended to help manage SIBO symptoms and support gut regularity. A narrative review published in Nutrients (2022) cited by the Institute for Natural Medicine identified psyllium as a fiber supplement that can help curb SIBO symptoms by supporting gut motility and microbiome balance without significantly increasing fermentable substrate.

Saccharomyces boulardii is a probiotic yeast with multiple RCTs demonstrating efficacy for SIBO. A 2024 randomized placebo-controlled study in patients with decompensated cirrhosis found SIBO absent in 80% of the probiotic group vs. 23.1% of placebo (p=0.002) after 3 months. A 2017 meta-analysis (18 studies, J Clin Gastroenterol) found probiotics including S. boulardii significantly reduced bacterial overgrowth and hydrogen breath test concentrations.

Thyme contains thymol, a phenolic compound with broad-spectrum antibacterial activity complementary to carvacrol from oregano oil. Thymol is active against gram-positive and gram-negative bacteria relevant to SIBO and enhances carvacrol's antimicrobial effects. Thyme extract is included in herbal SIBO protocols (regenerated.health) and its compounds are documented in SIBO antimicrobial literature.

Barberry's broad-spectrum antimicrobial activity, including against common small intestinal bacterial overgrowth pathogens, provides mechanistic plausibility for SIBO support. This is a traditional and mechanistically-inferred use rather than one supported by clinical SIBO-specific trials.

Caprylic acid is used by integrative practitioners for small intestinal bacterial/fungal overgrowth based on its broad antimicrobial properties. Its selective activity against Candida and some bacteria, combined with rapid absorption via the portal vein before reaching the distal gut, makes the SIBO rationale less direct than for colonic overgrowth. No human RCT exists for this specific indication.

Goldenseal is used in integrative and herbal medicine for small intestinal bacterial overgrowth (SIBO), based on berberine's documented antimicrobial activity against enteric bacteria. This is an extension of its traditional anti-infective gastrointestinal use; no RCTs of goldenseal for SIBO have been published.